BIO Events
BIO 2026: Generative genomics helps biotechs design better, not just faster
Generative genomics uses AI to analyze genetic sequences for innovative treatments. Every industry is racing to optimize AI in their operations. For many biotech research ...
Read More
Latest News
LATEST STORIES
Federal Policy
BIO applauds efforts targeting early drug development efficiency, provides suggestions
A Food and Drug Administration (FDA) pilot program to expedite approval of new drugs contains potentially impactful initiatives but risks adding burdens, says the Biotechnology ...
Federal Policy
PDUFA letter stresses stability, transparency, maturity, says BIO negotiator
An agreement designed to shape the future of drug approval recommends new efficiencies while leaning into the existing strengths of a system that makes America ...
BIO Events
BIO 2026: Generative genomics helps biotechs design better, not just faster
Generative genomics uses AI to analyze genetic sequences for innovative treatments. Every industry is racing to optimize AI in their operations. For many biotech research ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIO 2026: Generative genomics helps biotechs design better, not just faster
Generative genomics uses AI to analyze genetic sequences for innovative treatments. Every industry is racing to optimize AI in their operations. For many biotech research ...
Read More
BIO 2026: How biotechs break the $100M barrier in funding rounds
The tap is opening up for venture capital in the biotech industry. Venture investment in biotech jumped 23% year-over-year in 2025 to $23 billion, according ...
Read More